| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $944,416 ) |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 001 | 4 | NIH | 1/7/2025 | $534,040 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI181948 | Characterization of a novel kin recognition system in mycobacteria | 000 | 2 | NIH | 12/12/2024 | $442,353 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 000 | 6 | NIH | 12/12/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 001 | 5 | FDA | 1/8/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 000 | 5 | FDA | 11/7/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001342 | Extending New York State?s Biomonitoring Program for Assessing Disproportionate Exposure to Environmental Chemicals among Urban and Rural Communities | 01 | 1 | CDC | 10/21/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 000 | 3 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 03 | 2 | HRSA | 1/6/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM152716 | Development of polymer-based cell culture substrates for correlative light and electron microscopy (CLEM) | 000 | 1 | NIH | 12/17/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 005 | 2 | NIH | 11/22/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 003 | 2 | NIH | 11/4/2024 | $15,988 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM130298 | Efficiency and fidelity in mitotic spindle assembly | 000 | 5 | NIH | 11/8/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI132422 | Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria | 001 | 6 | NIH | 12/19/2024 | $111,150 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 004 | 2 | NIH | 11/22/2024 | $0 |
| | 2025 | 2021 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
| | 2025 | 2021 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI132422 | Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria | 000 | 5 | NIH | 12/19/2024 | -$111,150 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI125190 | Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines | 000 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 002 | 1 | NIH | 11/4/2024 | -$15,988 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 001 | 1 | NIH | 11/4/2024 | -$15,988 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 000 | 1 | NIH | 11/4/2024 | -$15,988 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $7,057,414 ) (Continued on the next page) |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI132422 | Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria | 000 | 7 | NIH | 7/23/2024 | $454,818 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001342 | Extending New York State?s Biomonitoring Program for Assessing Disproportionate Exposure to Environmental Chemicals among Urban and Rural Communities | 00 | 1 | CDC | 7/28/2024 | $837,500 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 001 | 3 | NIH | 6/27/2024 | $51,056 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 000 | 3 | NIH | 1/16/2024 | $459,507 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI168097 | Modeling the influence of temperature on the evolution of vector-virus interactions | 001 | 3 | NIH | 5/29/2024 | $48,823 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 02 | 2 | HRSA | 8/27/2024 | $12,800 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 01 | 2 | HRSA | 6/27/2024 | $0 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 01 | 2 | HRSA | 6/27/2024 | $0 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 00 | 2 | HRSA | 5/22/2024 | $131,440 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 00 | 2 | HRSA | 5/22/2024 | $213,560 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI168097 | Modeling the influence of temperature on the evolution of vector-virus interactions | 000 | 3 | NIH | 1/16/2024 | $439,418 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 000 | 6 | NIH | 5/17/2024 | $1,120,284 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM152716 | Development of polymer-based cell culture substrates for correlative light and electron microscopy (CLEM) | 000 | 1 | NIH | 9/18/2024 | $303,582 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM144361 | Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa | 001 | 3 | NIH | 7/23/2024 | $28,342 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM144361 | Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa | 000 | 3 | NIH | 1/24/2024 | $255,096 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI155473 | Role of ribosome modulating proteins in conferring Mycobacterium abscessus antibiotic resistance | 000 | 5 | NIH | 7/30/2024 | $470,217 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM143223 | Intraflagellar transport process in primary cilium maintenance | 000 | 4 | NIH | 5/30/2024 | $349,043 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 000 | 5 | FDA | 7/10/2024 | $923,065 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI181948 | Characterization of a novel kin recognition system in mycobacteria | 001 | 1 | NIH | 9/4/2024 | -$18,189 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI181948 | Characterization of a novel kin recognition system in mycobacteria | 000 | 1 | NIH | 1/30/2024 | $471,223 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01FD007143 | NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance | 000 | 5 | FDA | 8/30/2024 | $120,500 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI110112 | Latitudinal Landscape Genomics and Ecology of Anopheles Darlingi | 000 | 10 | NIH | 8/9/2024 | $419,524 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 02 | 5 | CDC | 5/23/2024 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 01 | 5 | CDC | 10/4/2023 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM139277 | Systematic Discovery and Analysis of Small Proteins and Small ORFs in Mycobacteria | 000 | 4 | NIH | 11/21/2023 | $0 |
|
